Kuano closes £1.8M seed funding round to validate quantum simulation platform for drug discovery

Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other Angel investors.

Cody Shandraw and Joseph Caltabiano On Real Estate’s Vital Role in Psychedelic Therapy

In this episode of the Psychedelic Spotlight Podcast, we put a spotlight on the unique and unsuspecting intersection where psychedelics and real estate are beginning

November 13, 2023

Metrohm helps pharma to bring their USP methods up to date

January 15, 2024

NX-1607 by Nurix Therapeutics for Head And Neck Cancer Squamous Cell Carcinoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.